GlassScriptPhysician profile
Pericles Stephen Hadjiyane
NPI 1750366449
$603.83
in general payments reported to CMS, 2019-2025
15 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $12.99 · 2021: $22.44 · 2023: $41.68 · 2024: $130 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $101.72 | 2019 | |
| Acadia Pharmaceuticals INC | $100.03 | 2019-2024 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $83.14 | 2019-2025 | Ultomiris |
| Amgen INC. | $48.14 | 2019 | |
| Genzyme Corporation | $36.87 | 2019 | |
| Abbvie INC. | $33.51 | 2023-2024 | |
| Sunovion Pharmaceuticals INC. | $27.35 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $24.96 | 2023 | Uzedy |
| Zyla Life Sciences, INC. | $24.65 | 2019 | |
| Octapharma USA, INC. | $24.04 | 2025 | Panzyga |
| Neurelis, INC. | $23.82 | 2024 | Valtoco |
| Ucb, INC. | $23.62 | 2025 | Zilbrysq |
| Allergan, INC. | $22.44 | 2021 | |
| Scilex Pharmaceuticals INC. | $14.88 | 2019 | |
| Eisai INC. | $14.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pericles Hadjiyane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.